Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Luke Evnin currently holds 107,429 shares of Werewolf Therapeutics, Inc. (HOWL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Luke Evnin has been a net seller of HOWL stock. They have purchased $42.8M and sold $100.8M worth of shares.
Luke Evnin's most recent insider trade was on Jul 7, 2026, when they sold 107,429 shares at $0.31 per share.
Luke Evnin serves as Executive at Werewolf Therapeutics, Inc. (HOWL). They have executed 235 insider transactions totaling $143.6M over their tenure at the company.
Luke Evnin holds the position of Executive at Werewolf Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Luke Evnin has shown a selling trading pattern, with $42.8M in total purchases and $100.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Luke Evnin was on May 8, 2026, when they sold $214.0K worth of HOWL shares. This transaction involved 305,741 shares at $0.70 per share.
Luke Evnin currently owns 107,429 shares of Werewolf Therapeutics, Inc. (HOWL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Luke Evnin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Luke Evnin has 235 Form 4 filings on record as an insider at Werewolf Therapeutics, Inc..
Set alerts for Luke Evnin and 40,000+ other insiders.